Emunamedica is a leading diagnostics company that has developed a patented and clinically-tested system designed to assess whether a chronic wound, such as a diabetic foot ulcer will heal given the current course of therapy.
Currently there are NO accurate quantitative diagnostics available to clinicians to help them assess whether a chronic wound will heal. This leads to patients staying on the wrong therapy for far too long, wasting valuable tissue healing time and hundreds of millions of healthcare dollars for payers.
Chronic wounds affect over 6 million people in the United States alone and cost health insurers, including Medicare nearly $10 billion annually. This figure is growing at 8% per year with about 1 in every 6 diabetics getting at least one chronic wound in their lifetime.
Company’s Keywords:
<1
<2000000
<
<2006